Category: Hepatitis C

Survey participants with hep C or living with/caring for someone with hep C needed immediately! Take this survey! The Canadian Agency for Drugs and Technologies in Health (CADTH) is currently seeking patient group input reports for ombitasvir / paritaprevir / ritonavir and dasabuvir, developed by AbbVie. Thus, Pacific Hepatitis C Network (PHCN) needs your help… Read more »

CATIE’s HepCInfo Update 5.21

New and Noteworthy Interactions with transplant drugs added to simeprevir product monograph The U.S. Food and Drug Administration (FDA) recently approved revisions to the product label information for the direct-acting anti-viral medication simeprevir, known by the brand name Galexos in Canada. The revisions highlighted drug interactions with cyclosporine and tacrolimus, which are used to prevent… Read more »

CATIE’s HepCInfo Update 5.19

New and Noteworthy CATIE-News: A hepatitis C outbreak among HIV-negative gay men in London, England Some HIV-negative gay men may be at risk for getting hepatitis C. Researchers from London, England found 44 cases of acute Hep C infection in HIV-negative gay men between 2010 and 2014. Among HIV-positive gay men, hepatitis C has been… Read more »

Take this survey It is 36, mostly multiple choice, questions that are divided into 5 sections. Sections that don’t pertain to you can be easily skipped. The survey’s 5 sections ask about: The impact of hep C on your life (8 questions) Your experience with current hep C treatments (9 questions) The impact on caregivers… Read more »

CATIE’s HepCInfo Update 5.17

New and Noteworthy Expanded harm reduction services decreased new Hep C infections in Scotland Implementing comprehensive harm reduction services averted an estimated 1400 new Hep C infections in Scotland, reported researchers in PLOS ONE. In 2008, the Scottish government expanded access to sterile injecting equipment, including needles, syringes, cookers, filters and water, and improved access… Read more »

CATIE’s HepCInfo Update 5.15

New and Noteworthy High risk of Hep C among Vancouver street youth From 2005 to 2011, 940 youth were recruited into the At-Risk Youth Study. All youth completed an initial Hep C test and just over 10% were found to be Hep C positive. Of the 512 Hep C-negative youth who were retested every six… Read more »

CATIE’s HepCInfo Update 5.14

New and Noteworthy Health Canada approves a stand-alone ribavirin pill Health Canada has approved a stand-alone ribavirin pill known by the brand name Ibavyr. Traditionally, ribavirin has been available for Hep C treatment in combination with peg-interferon. A stand-alone ribavirin pill is necessary for some treatments with sofosbuvir (Sovaldi) as well as other interferon-free combinations… Read more »

World Hepatitis Day Vancouver 2014: Vancouver BC Canada

Everyone welcome! GREAT GUEST SPEAKERS Medical experts & “positive” people 1-hour exciting new Canadian FILM ABOUT HEPATITIS C HEPATITIS B and C INFORMATION BOOTHS from local organizations   World Hepatitis Day Vancouver 2014 Planning Committee includes representatives from: S.U.C.C.E.S.S., the BC Centre for Excellence in HIV/AIDS, HepCBC Hepatitis C Education and Prevention Society, the BC… Read more »

Sage is a community-driven space for organizations and other HIV and hepatitis C service providers in Canada to share and archive their digital information resources and connect with peers in the field. Examples of recently added resources: Opposites Attract: A Guide for Magnetic Relationships Moving Knowledge into Action: An evaluation of the impact of CATIE’s… Read more »